Assessing Acute and Long-Term Toxicities of Proton Radiation Therapy in Pediatric Pelvic Tumors: Findings From the Pediatric Proton Consortium Registry. Pediatric Blood and Cancer. 2025; e31811.
.Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies. Cancer. 2025; 131:e35713.
.2025; 85:lb266.
. Abstract LB266: A multicenter phase 1-2a clinical study of Orotecan® (oral irinotecan HCl, VAL-413) in patients with recurrent pediatric solid tumors. Cancer Research.2025; 31:s60-s61.
. Impact of Graft Versus Host Disease Following Allogeneic Hematopoietic Cell Transplantation on Leukemia Free Survival in Hematologic Malignancies: A CIBMTR Analysis. Transplantation and Cellular Therapy.A Single-Cell Transcriptome Atlas of Epithelial Subpopulations in HPV-Positive and HPV-Negative Head and Neck Cancers. Viruses-Basel. 2025; 17:461.
.2025; 31:s375-s376.
. Beyond Survival: Assessing Renal and Cardiovascular Health in Fanconi Anemia Adolescents and Young Adults Post-Stem Cell Transplant. Transplantation and Cellular Therapy.2025; 31:s145-s146.
. Differential Filtration of Macromolecules: A Novel Indicator of Mortality Risk in Pediatric HSCT Patients. Transplantation and Cellular Therapy.2025; 22.
. GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias.2025; 6:13.
. The Current Landscape of Molecular Pathology for the Diagnosis and Treatment of Atypical Teratoid Rhabdoid Tumor. Journal of Molecular Pathology."From Drowning to Treading Water ": Adolescents and Young Adults Living with Incurable and Indolent Metastatic Soft Tissue Sarcoma for More than Two Years. Cancers. 2025; 17:442.
.2025; 53.
. 667: SEVERE METHOTREXATE-INDUCED NEUROTOXICITY IN A HISPANIC ADOLESCENT GIRL WITH B-ALL. Critical Care Medicine.A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors. Pediatric Blood and Cancer. 2025; 72:e31692.
.Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas. Journal of Clinical Oncology. 2025; 43:1843-1844.
.Spatial Profiling Identifies Regionally Distinct Microenvironments and Targetable Immunosuppressive Mechanisms in Pediatric Osteosarcoma Pulmonary Metastases. Cancer Research. 2025; 85:2320-2337.
.2025; 3:72-87.
. BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023.Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment. Ear and Hearing. 2025; 46:286-297.
.DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers. 2025; 17:83.
.Feasibility and Safety of Intratympanic Administration of Sustained-Exposure Dexamethasone Thermosensitive Gel (OTO-104) for Prevention of Cisplatin-Induced Hearing Loss in Children: A Multisite Phase 2 Randomized Clinical Trial. Pediatric Blood and Cancer. 2025; 72:e31680.
.Elevated Bromide Levels Due to Tazemetostat Therapy Treated With Salt and Water Supplementation in Two Children With Atypical Teratoid Rhabdoid Tumor. Pediatric Blood and Cancer. 2025; 72:e31803.
.CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines. Editor, Li M. PloS one. 2025; 20:e0306846.
.Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study-5 and Children's Oncology Group Study AREN0321. Pediatric Blood and Cancer. 2025; 72:e31490.
.T2-weighted MRI radiomics for the prediction of pediatric and young adult rhabdomyosarcoma alveolar subtype and distant metastasis: a pilot study. Pediatric Radiology: roentgenology, nuclear medicine, ultrasonics, CT, MRI. 2025; 55:1149-1161.
.The Threat of Medical Misinformation: A Case of Ivermectin Toxicity in a Pediatric Oncology Patient. Pediatric Blood and Cancer. 2025; 72:e31876.
.A novel POT1-TPD presentation: A germline pathogenic POT1 variant discovered in a patient with newly diagnosed posterior fossa ependymoma. Cancer genetics. 2025; 292-293:38-43.
.Shining a TORCH on a Case of Blueberry Muffin Rash in a Newborn Infant. NeoReviews.org. 2025; 26:e191-e196.
.2025; 22.
. DARA to Believe: Anti-CD38 Antibody Improves Outcomes in Relapsed/Refractory Pediatric T-Cell Lymphoblastic Leukemia and Lymphoma.Impact of Hepatoblastoma on Infectious Complications Following Pediatric Liver Transplantation. Pediatric Transplantation. 2025; 29:e70035.
.Posttransplant EBV-Positive Smooth Muscle Tumors in Children, Adolescents, and Young Adults: A Multi-Institution Experience. Pediatric Blood and Cancer. 2025; 72:e31678.
.IRAK1/4/pan-FLT3 Kinase Inhibitors with Reduced hERG Block as Treatments for Acute Myeloid Leukemia. ACS Medicinal Chemistry Letters. 2025; 16:887-895.
.Radiomic-based prognostic score for survival risk-stratification in pediatric medulloblastoma tumors: A multi-institutional study. Neuro-Oncology Advances. 2025; 7:vdaf107.
.DEK promotes mammary hyperplasia and is associated with H3K27me3 epigenetic modifications. Life Science Alliance. 2025; 8:e202503230.
.Systematic Review of Pain Assessment Measures Used in Pediatric Acute Lymphoblastic Leukemia. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer. 2025; 34:e70063.
.2025; 6:11.
. The Current Landscape of Molecular Pathology for the Diagnosis and Treatment of Pediatric Medulloblastoma. Journal of Molecular Pathology.Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR). Journal of Neuro-Oncology. 2025; 174:369-380.
.2025.
. Medulloblastoma of early childhood. Salvage and outcome after initial CSI sparing approaches.Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions. Clinical Cancer Research. 2025; 31:561-572.
.2025; 31:s509-s510.
. Effect of Clinically Relevant Immunosuppressants on Viral Specific T-Cell (VST) in Vitro Function. Transplantation and Cellular Therapy.Developing Behavior Change Model-Informed and Participant-Engaged Retention Strategies for Adolescents and Young Adults With Cancer Enrolled on Behavioral and/or Psychosocial Trials. Pediatric Blood and Cancer. 2025; 72:e31583.
.Phase 1 study of quercetin, a natural antioxidant for children and young adults with Fanconi anemia. Blood Advances. 2025; 9:1927-1939.
.2025; 13:11-16.
. Quality of Life for Rural and Appalachian Pediatric Brain Tumor Survivors in Ohio and Kentucky. Clinical Practice in Pediatric Psychology.Acute Toxicities of Proton Craniospinal Irradiation in Pediatric Medulloblastoma: A Pediatric Proton/Photon Consortium Registry (PPCR) Study. International Journal of Particle Therapy. 2025; 16:100747.
.Neurocognitive outcomes and functional independence in adult survivors of childhood medulloblastoma diagnosed over 3 decades. Neuro-Oncology. 2025; 27:254-266.
.Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers. Nature Reviews Urology. 2025; 22:526-543.
.2025; 22.
. ‘Blin’-ing Is Winning for Children With B-Cell Acute Lymphoblastic Leukemia.2025; 10:104332.
. 23P Pre-diagnostic imaging reveals rapid emergence and progression of small cell carcinoma of the ovary hypercalcemic type (SCCOHT): Implications for monitoring carriers of SMARCA4 germline pathogenic variants (GPVs). ESMO Open.In: Stubblefield M; O'Dell M, Ed. Cancer Rehabilitation. New York: Springer Publishing Company; 2025.
. Rehabilitation of the Pediatric Cancer Patient.Isotretinoin has no effect on event-free survival across high-risk medulloblastoma molecular groups when added to maintenance: A secondary analysis of the Children's Oncology Group ACNS0332 data. Neuro-Oncology Advances. 2025; 7:vdaf054.
.Lymphoid malignancies in patients with Shwachman-Diamond syndrome. Blood. 2025; 145:2528-2532.
.2025; 31:s219.
. Kymriah Real-World Effectiveness and Functional Persistence in Acute Lymphoblastic Leukemia (ALL) (KareALL): A Retrospective Analysis of the Effect of Current Tisagenlecleucel (tisa-cel) Manufacturing in Pediatric and Young Adult Patients (pts) with ALL. Transplantation and Cellular Therapy.2025; 85:3155.
. Abstract 3155: High-throughput drug repositioning identifies dinaciclib as a potent osteosarcoma inhibitor. Cancer Research.2025; 5:100235.
. Global consensus from the PHITT consortium surrounding an interim chemotherapy guidance for the treatment of children with hepatoblastoma, hepatocellular neoplasm – not otherwise specified (HCN-NOS), hepatocellular carcinoma and fibrolamellar carcinoma after trial closure. EJC Paediatric Oncology.2025; 5:100211.
. Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients – A narrative literature review to explore the potential benefit for children with cancer. EJC Paediatric Oncology.Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives. Pediatric Blood and Cancer. 2025; 72:e31790.
.Essential Knowledge and Skills for the Practice of Pediatric Surgical Oncology: A Modified Delphi Consensus Study by the APSA Cancer Committee. Annals of Surgical Oncology. 2025; 32:5752-5771.
.Characteristics of patients with liver tumors deemed ineligible for enrollment on Children's Oncology Group trial AHEP1531: An opportunity to expand inclusion criteria and improve outcome. Pediatric Blood and Cancer. 2025; 72:e31389.
.2025; 6:17.
. The Current Landscape of Molecular Pathology for the Diagnosis and Treatment of Pediatric High-Grade Glioma. Journal of Molecular Pathology.Using cancer phenotype sex-specificity to enable unbiased penetrance estimation of SMARCA4 pathogenic variants for small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). Genetics in Medicine. 2025; 27:101287.
.2025; 22.
. First Relapse, Second Chance: Determinants of Survival After First Relapse in Pediatric Acute Lymphoblastic Leukemia.